March 29, 2023
Life Sciences | Tea Leaves
  • The Food and Drug Administration scheduled a May advisory meeting to discuss if HRA Pharma’s birth control pill should be available over the counter, an approval that would be the first of its kind from the agency. FDA advisers originally planned to review the drug in November of last year, but the date was pushed back to review additional information. The pill, called Opill from French drugmaker HRA Pharma, is currently approved by the FDA to prevent pregnancy, but it is only available with a prescription. (Articles here and here)